Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by PsychoGenics Inc.
PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor for the Treatment of Neuropsychiatric Disorders
December 01, 2023
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics Launches an Updated Corporate Identity and Brand
November 10, 2023
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant to use AI platforms to design new drugs for mental health disorders
September 05, 2023
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
April 06, 2023
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics Announces Extension of Ongoing Drug Discovery Collaboration with Karuna Therapeutics
October 11, 2022
From
PsychoGenics Inc.
Via
Business Wire
Tickers
KRTX
PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities
June 28, 2022
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics’ High Data Security Standards Are Certified by The NIH
January 12, 2022
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development
December 14, 2021
From
PsychoGenics Inc.
Via
Business Wire
PsychoGenics Chief Innovation Officer Honored for Scientific Excellence
September 23, 2021
From
PsychoGenics Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.